Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Carbocisteine Reduces COPD Flare-Ups
Link ID 6685
Title Carbocisteine Reduces COPD Flare-Ups
Url http://www.medscape.com/viewarticle/575998?src=rss
Description Treatment with carbocisteine, a mucolytic drug with anti-inflammatory and antioxidant effects, can significantly reduce the yearly exacerbation rate in patients with chronic obstructive pulmonary disease (COPD), the results of a Chinese study indicate. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Jun 14, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. FDA Grants Additional Indication for Rosuvastatin
  The Food and Drug Administration has approved a new indication for rosuvastatin to slow the progression of atherosclerosis in patients with elevated cholesterol. Medscape Medical News
Category:   Articles > Pharmacists


2. Financial Crisis to Increase Mental Health Woes: WHO
  The global financial crisis is likely to cause increased mental health problems and even suicides as people struggle to cope with poverty and unemployment, the World Health Organisation warned on Thursday. Reuters Health Information
Category:   Articles > Pharmacists


3. Pfizer Wins Ruling That May Limit Celebrex Suits
  Pfizer Inc has won a U.S. court ruling that could limit the lawsuits claiming that its Celebrex painkiller caused heart attacks and strokes. Reuters Health Information
Category:   Articles > Pharmacists


4. Advances in Treatment for Ankylosing Spondylitis and Other Rheumatic Conditions -- Efficacy and Safe
  Dr. Alan Matsumoto reviews data from ACR 2007 on the efficacy and safety of anti-TNF therapy for ankylosing spondylitis, psoriatic arthritis, and sarcoidosis.
Medscape Rheumatology
Category:   Articles > Pharmacists


5. Imatinib Effective Over Long Term in Refractory Leukemia
  Imatinib mesylate therapy shows lasting safety and efficacy in chronic-phase chronic myeloid leukemia (CML) patients in whom interferon-alpha treatment has failed. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS